drugset / Trial / NCT00171327

Efficacy and Safety of Fluvastatin or Valsartan and Their Combination in Dyslipidemic Patients With Hypertension and Endothelial Dysfunction

NCT00171327

Phase 4 Completed 213 enrolled Novartis
RandomizedParallel-groupOpen-labelTreatment

Summary

Patients with mild to moderate hypertension, dyslipidemia (imbalanced blood lipids) and decreased vascular dilatation, receiving a cholesterol lowering diet were given either valsartan or fluvastatin for 8 weeks. At week 8 all patients were administered a combination treatment with valsartan 160 mg and fluvastatin 80 mg.

Timeline

Start
2004-07
Primary completion
2005-09
Completion
2005-09

Drugs

EvaluationDrugModalityDoseRoute
Subject Fluvastatin Other / unclassified 80 mg
Subject Valsartan Small molecule 160 mg